Prostate Cancer Clinical Trial
This prospective study at MAMC evaluates the utility of a rigid pelvic external
immobilization compared to limited immobilization using a novel real-time localization
system of the prostate. The sample population will include patients referred to the
radiation oncology services of both facilities for definitive treatment of prostate cancer.
The study will enroll 20 subjects from MAMC and evaluate data on 860 radiation therapy
fractions.
Subjects will have Beacon® Transponders implanted into the prostate to more precisely
localize the position of the organ during radiation therapy. They will be randomized to
rigid pelvic immobilization using a Vac-Lok® system or limited immobilization with a band
around the patient's feet. They will then undergo radiation therapy planning with standard
planning target margins. The Calypso® 4D Localization System will monitor, in real time, the
position of the prostate target and adjust radiation treatments as required to ensure
accurate treatment of the prostate gland. The time of, the number, and extent of adjustments
will be recorded for analysis.
Hypothesis: 1. When treating only the prostate, treatment with rigid pelvic immobilization
is not necessary when using real-time, state-of-the-art motion tracking of the prostate.
Medical application: This study will seek to determine the utility of rigid external pelvic
immobilization in patients who are set up using real-time, state-of-the-art motion tracking
of the prostate. External immobilization devices have been criticized for being expensive,
uncomfortable, time-consuming to make, occupying a lot of space in the treatment area,
creating difficulties at the time of CT simulation, challenging for obese patients and
obscuring skin marks that can help confirm patient set up. Omitting these devices (if found
to be unnecessary) would potentially decrease treatment costs, improve patient comfort
during treatment, and reduce overall treatment time. In high risk patients, gaining a better
understanding of lymph node positioning relative to Calypso immobilization may allow for
decreased PTV margins and therefore decreased normal tissue irradiated during radiation
therapy.
Objective(s) of the investigation: This study will look at the efficacy of external pelvic
immobilization in definitive radiation therapy of prostate cancer using a unique organ
tracking system.
A. Primary Objective: To determine if rigid external pelvic immobilization demonstrates a
reduction in positioning errors. This will be assessed by determining the median, mean and
range of shifts performed in all 3 dimensions as part of initial isocenter set-up and during
treatment using the Calypso system.
B. Secondary Objectives: The study will determine the simulation time, set up time,
treatment time, total time and number of treatment interventions (repositioning/pausing)
caused by organ/target motion beyond planning target volume (PTV) margin using real time
localization. In the subset of high-risk patients, this study will assess positioning of the
lymph node target using the combination of rigid external pelvic immobilization and the
Calypso system.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |